Laxative Properties of Microencapsulated Oleic Acid Delivered to the Distal Small Intestine in Patients with Constipation after Bariatric Surgery or Treatment with Glucagon-Like- Peptide 1 Analogues.
微膠囊包覆的油酸在接受減重手術或使用Glucagon-Like Peptide 1 類似物的便秘患者中,對於遠端小腸的瀉藥特性。
Obes Surg 2024-09-05
Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides.
葉酸修飾的逆微胞脂質奈米膠囊克服腸道障礙並改善肽的口服給藥。
Drug Deliv 2023-03-04
Effects of Treatment with Liraglutide Early after Surgical Intervention on Clinical Outcomes in Patients with Short Bowel Syndrome: A Pilot Observational "Real-Life" Study.
手術後早期使用利拉魯肽治療對短腸症患者臨床結果的影響:一項初步觀察性「真實生活」研究。
Nutrients 2023-07-01
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations.
首例人體研究顯示,藥物性十二指腸排除療法可降低進餐後血糖和胰島素,並增加膽酸和腸道激素濃度。
Diabetes Obes Metab 2023-08-03
Oligofructose improves small intestinal lipid-sensing mechanisms via alterations to the small intestinal microbiota.
寡果寡糖透過改變小腸微生物群,改善小腸脂質感知機制。
Microbiome 2024-01-01
Emerging uses of glucagon-like peptide 1 (GLP-1) receptor agonists following ileal resection: literature review and case examples.
腸末端切除後胰高血糖素樣肽-1(GLP-1)受體激動劑的新興用途:文獻回顧與案例示例。
Frontline Gastroenterol 2023-10-20
Efficacy and Safety of Liraglutide in Patients With an Ileal Pouch-Anal Anastomosis and Chronic High Bowel Frequency: A Placebo-Controlled, Crossover, Proof-of-Concept Study.
Liraglutide在患有回盲肛吻合术和慢性高腸頻率的患者中的療效和安全性:一項安慰劑對照、交叉、概念驗證研究。
Am J Gastroenterol 2024-05-22
Glucagon-like Peptide-1 Receptor Agonists and Capsule Endoscopy in Patients with Diabetes: A Matched Cohort Study.
糖尿病患者中胰高血糖素樣肽-1受體激動劑與膠囊內視鏡的配對隊列研究。
Gastrointest Endosc 2024-08-02
Rebalancing the Gut: Glucagon-Like Peptide-1 Agonists as a Strategy for Obesity and Metabolic Health.
重新平衡腸道:Glucagon-Like Peptide-1 受體激動劑作為肥胖和代謝健康的策略。
Cureus 2024-08-19